In order to investigate whether a licensed human medication with known PAF receptor blockade activity could also affect dengue sera-induced vascular permeability, human umbilical vein derived endothelial cell lines (HUVEC) were incubated with PAF and/or acute dengue sera in the presence or absence of rupatadine. Here, PCLAF is linked to dengue disease.